Myriad Genetics (MYGN) Income towards Parent Company: 2009-2024
Historic Income towards Parent Company for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to -$127.3 million.
- Myriad Genetics' Income towards Parent Company fell 23.98% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$400.5 million, marking a year-over-year decrease of 245.26%. This contributed to the annual value of -$127.3 million for FY2024, which is 51.65% up from last year.
- Latest data reveals that Myriad Genetics reported Income towards Parent Company of -$127.3 million as of FY2024, which was up 51.65% from -$263.3 million recorded in FY2023.
- Myriad Genetics' Income towards Parent Company's 5-year high stood at -$27.2 million during FY2021, with a 5-year trough of -$263.3 million in FY2023.
- In the last 3 years, Myriad Genetics' Income towards Parent Company had a median value of -$127.3 million in 2024 and averaged -$167.5 million.
- Per our database at Business Quant, Myriad Genetics' Income towards Parent Company plummeted by 6,337.50% in 2020 and then spiked by 87.84% in 2021.
- Myriad Genetics' Income towards Parent Company (Yearly) stood at -$199.6 million in 2020, then reached -$223.7 million in 2020, then surged by 87.84% to -$27.2 million in 2021, then crashed by 311.76% to -$112.0 million in 2022, then crashed by 135.09% to -$263.3 million in 2023, then soared by 51.65% to -$127.3 million in 2024.